Using the wrong materials or skipping a step in hygiene can lead to contamination or inaccurate dosing
The majority of the reported events occurred in patients who had experienced gastrointestinal reactions leading to dehydration such as nausea, vomiting, or diarrhea
Selection of patients : It may be that benefits are strongest in those with early metabolic dysfunction, mild cognitive impairment, or early Alzheimers disease, rather than in advanced dementia
Prevalence varies by medication and dose
By 5 mg, most patients notice a clearer drop in appetite and the first meaningful GI adjustment period, typically the most noticeable nausea of the entire titration process
Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors (dual agonist)